Clinical trial
A Prospective, Multicenter Trial of NOYA Sirolimus-Eluting Stent With Biodegradable Coating in Patients With Coronary Artery Disease
NCT02216058 is registered in ClinicalTrials.gov with Medfavour (Beijing) Medical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Trial of NOYA Sirolimus-Eluting Stent With Biodegradable Coating in Patients With Coronary Artery Disease
- Lead sponsor
- Medfavour (Beijing) Medical Co., Ltd
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2013
- Completion date
- June 30, 2020
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.